Ethos Technologies Inc. Class A Common Stock (LIFE)vsMarsh & McLennan Companies, Inc. (MRSH)
LIFE
Ethos Technologies Inc. Class A Common Stock
$42.83
+0.71%
FINANCIAL SERVICES · Cap: $2.80B
MRSH
Marsh & McLennan Companies, Inc.
$192.30
+0.85%
FINANCIAL SERVICES · Cap: $93.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Marsh & McLennan Companies, Inc. generates 4752% more annual revenue ($28.46B vs $586.53M). MRSH leads profitability with a 14.2% profit margin vs -18.1%. MRSH earns a higher WallStSmart Score of 62/100 (C+).
LIFE
Avoid34
out of 100
Grade: F
MRSH
Buy62
out of 100
Grade: C+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 113.4% year-over-year
Conservative balance sheet, low leverage
Large-cap with strong market position
Every $100 of equity generates 28 in profit
Generating 1.4B in free cash flow
Areas to Watch
ROE of -24.4% — below average capital efficiency
Earnings declined 5.3%
Distress zone — elevated risk
Currently unprofitable
Expensive relative to growth rate
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : LIFE
The strongest argument for LIFE centers on Revenue Growth, Debt/Equity. Revenue growth of 113.4% demonstrates continued momentum.
Bull Case : MRSH
The strongest argument for MRSH centers on Market Cap, Return on Equity, Free Cash Flow.
Bear Case : LIFE
The primary concerns for LIFE are Return on Equity, EPS Growth, Altman Z-Score.
Bear Case : MRSH
The primary concerns for MRSH are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 1.52 is elevated, increasing financial risk.
Key Dynamics to Monitor
LIFE profiles as a hypergrowth stock while MRSH is a value play — different risk/reward profiles.
LIFE is growing revenue faster at 113.4% — sustainability is the question.
MRSH generates stronger free cash flow (1.4B), providing more financial flexibility.
Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRSH scores higher overall (62/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ethos Technologies Inc. Class A Common Stock
FINANCIAL SERVICES · INSURANCE BROKERS · USA
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Marsh & McLennan Companies, Inc.
FINANCIAL SERVICES · INSURANCE BROKERS · USA
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.
Compare with Other INSURANCE BROKERS Stocks
Want to dig deeper into these stocks?